ArticleBMC public health2025
Burdens and patterns of gastrointestinal diseases in Thai children: an analysis based on Thai national health coverage data.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal (GI) diseases are significant health problems worldwide. Due to the limited number of national reports among upper-middle-income countries, we aimed to study burdens and patterns of GI diseases in Thai children.
methodsThe study retrospectively analyzed data on inpatients aged <18 years provided by Thailand’s National Health Security Office (NHSO) from 2015 to 2023.
resultsThe primary diagnosis of GI diseases during the study period ranged from 134,000 to 296,040 admissions per year (10.2-16% of all inpatient diagnoses). The most common diagnosis group was intestinal infectious diseases (58.6%-66.3%), of which other gastroenteritis and colitis of infectious and unspecified origin (A09) was prevalent in every age group. Admission mainly was found among children aged 1-5 years (36.5%-48.1%) and in the secondary hospitals (67.8-71.2%). In 2015-2022, the mortality rate of GI diseases was 0.5-0.7 deaths per 1,000 admissions (2.3-3.2% of the total inpatient deaths). In 2023, the mortality rate of GI diseases reduced to 0.4 deaths per 1,000 admissions, describing the highest rates in the groups of malignant neoplasms of digestive organs and diseases of the peritoneum (17.4 deaths per 1,000 admissions, both), followed by diseases of the liver (15.1 deaths per 1,000 admissions). Hepatic failure, not elsewhere classified (K72), had the highest mortality (106.4 deaths per 1,000 admissions). The total paid by the NHSO for GI diseases was 77,370,498 Thai Baht or 2,230,790 US dollars in the fiscal year 2022-2023.
conclusionsPediatric GI diseases burdened the Thai healthcare system, particularly intestinal infectious diseases. Malignancy, peritoneal, and liver diseases had less prevalence but higher mortality. TRIAL REGISTRATION NUMBER: TCTR20241030014 ( https://www.thaiclinicaltrials.org/show/TCTR20241030014 ), Date of Registration: 19/9/2024.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.